QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)
QQQ   388.83 (-0.25%)
AAPL   189.95 (+0.31%)
MSFT   378.91 (+0.02%)
META   327.15 (-1.52%)
GOOGL   132.53 (-1.82%)
AMZN   146.09 (-0.16%)
TSLA   240.08 (-1.66%)
NVDA   467.70 (-2.85%)
NIO   7.28 (+1.39%)
BABA   74.86 (+0.25%)
AMD   121.16 (-2.17%)
T   16.57 (+1.66%)
F   10.28 (-2.93%)
MU   76.12 (-0.74%)
CGC   0.56 (+0.00%)
GE   121.74 (+2.42%)
DIS   92.69 (+0.21%)
AMC   6.65 (-7.39%)
PFE   30.44 (+1.20%)
PYPL   57.61 (-0.62%)
XOM   102.80 (+0.45%)

Aphria Stock Price, News & Analysis (NASDAQ:APHA)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$15.38
▼
$15.38
50-Day Range
$13.14
▼
$18.37
52-Week Range
$2.78
▼
$32.29
Volume
N/A
Average Volume
21.83 million shs
Market Capitalization
$4.87 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

APHA stock logo

About Aphria Stock (NASDAQ:APHA)

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.


APHA Stock News Headlines

September 27, 2023 | benzinga.com
Sheep Ate 600lbs Of Cannabis While Sheltering From A Storm: Here's What They Did Next
September 25, 2023 | markets.businessinsider.com
Ewe Won't Believe It: Greek Sheep's 'Highly' Unconventional Cannabis Greenhouse Adventure
November 30, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
June 8, 2023 | markets.businessinsider.com
Tilray CFO Engages Shareholders On Reddit, Addresses Concerns And Company's Growth Strategy
January 3, 2023 | nypost.com
How to bet on Horse Racing: Complete guide to Horse Betting Online
October 14, 2022 | fool.com
Why Owens & Minor Shares Plummeted 32.4% This Week - The Motley Fool
October 11, 2022 | prnewswire.com
The Continued Legalization of Cannabis Creates Need for Intoxication Detection Devices - PR Newswire
October 10, 2022 | finance.yahoo.com
Industrial hemp Market Size-2022 Will Revenue to Cross readjusted size of US$ 3259.5 million by 2028 Top Companies report covers, (It was also one of the primary plants to be rolled into usable fibre 50,000 years ago.) - Yahoo Finance
November 30, 2023 | Autonomix (Ad)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
October 8, 2022 | seekingalpha.com
Tilray Brands Stock: Pot Pops Then Drops - Seeking Alpha
October 7, 2022 | law360.com
JPay Founder Says Insider Trading Case Falls Short - Law360
October 4, 2022 | businesswire.com
Global Medical Marijuana Market Trends/Analysis Report 2022: A $65.8 Billion Industry by 2030 - Rapid Adoption of Cannabis in Therapeutic Applications - ResearchAndMarkets.com - Business Wire
October 1, 2022 | prnewswire.com
Global Cannabis Extract Market to Reach $15.5 Billion by 2030 at a CAGR of 20.6% - PR Newswire
September 28, 2022 | businesswire.com
Global Legal Cannabis Market Size, Trends & Analysis Report 2022-2030: Regulatory Scenario, Consumption Pattern, Potential Trade Opportunities, Case Studies, End-users, Competitive Landscape - ResearchAndMarkets.com - Business Wire
September 27, 2022 | globenewswire.com
Cannabis Beverages Market to Reach USD 19,063.58 Million by - GlobeNewswire
September 26, 2022 | finance.yahoo.com
Global Legal Cannabis Market Analysis Report 2022: A $134.4 Billion Industry by 2030, Growing at a CAGR of Over 25% - Yahoo Finance
September 17, 2022 | seekingalpha.com
TLRY Tilray Brands, Inc.
September 14, 2022 | globenewswire.com
With 27.5% CAGR, Global CBD-Infused Beverages Market Size - GlobeNewswire
September 13, 2022 | prnewswire.com
YourWay Cannabis Brands Provides Corporate Update - PR Newswire
September 13, 2022 | businesswire.com
Morganti & Co., Announces that Class Certification Scheduled in the pending shareholder litigation against Auxly Cannabis Group, Inc. - Business Wire
September 11, 2022 | benzinga.com
Joana Scopel
September 10, 2022 | benzinga.com
Tilray Brands (NASDAQ:TLRY) – A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In C - Benzinga
September 7, 2022 | investors.com
Is TLRY Stock A Buy As Germany Gets Closer To Cannabis Legalization? - Investor's Business Daily
September 2, 2022 | seekingalpha.com
TLRY stock gains after debt agreement with JV partner (NASDAQ:TLRY) - Seeking Alpha
September 1, 2022 | law360.com
Canadian Pot Co. Investors Win Class Cert. In Acquisition Suit - Law360
August 31, 2022 | globenewswire.com
Industrial Hemp Market Worth USD 3259.5 million by 2028 | Growth, Size, Shares, Revenue, Types, Applications, Key Players, Top Countries, Growing Factors, Key Dynamics - GlobeNewswire
August 25, 2022 | finance.yahoo.com
Tilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada - Yahoo Finance
See More Headlines
Receive APHA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aphria and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/11/2021
Today
11/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medicinals & Botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APHA
CUSIP
N/A
CIK
N/A
Web
aphriainc.com
Phone
(844) 427-4742
Fax
N/A
Employees
1,200
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-63,210,000.00
Net Margins
-36.10%
Pretax Margin
N/A
Return on Equity
-2.30%
Return on Assets
-1.66%

Debt

Debt-to-Equity Ratio
0.25
Current Ratio
2.36
Quick Ratio
1.17

Sales & Book Value

Annual Sales
$405.96 million
Price / Sales
12.00
Cash Flow
$0.09 per share
Price / Cash Flow
166.43
Book Value
$4.80 per share
Price / Book
3.20

Miscellaneous

Outstanding Shares
316,795,000
Free Float
N/A
Market Cap
$4.87 billion
Optionable
Optionable
Beta
2.67
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Irwin D. Simon (Age 62)
    CEO & Chairman
    Comp: $5.23M
  • Mr. Carl A. Merton
    Chief Financial Officer
  • Dr. Christelle Gedeon L.L.B.
    Ph.D., Chief Legal Officer & Corp. Sec.
  • Mr. James R. Meiers
    Chief Operating Officer of Aphria Leamington
  • Ms. Denise Menikheim Faltischek (Age 48)
    Chief Strategy Officer & MD of Aphria Germany
    Comp: $449.68k
  • Mr. John B. Sadler
    VP of Investor Relations
  • Mr. Bernard Yeung
    Sr. VP of Sales & Marketing
  • Mr. Victor Neufeld (Age 67)
    Special Advisor
  • Mr. Cole Cacciavillani (Age 66)
    Special Advisor
  • Mr. Randy Daigneau
    Sr. VP of Supply Chain

Key Competitors

View All Competitors














APHA Stock Analysis - Frequently Asked Questions

How were Aphria's earnings last quarter?

Aphria Inc. (NASDAQ:APHA) released its quarterly earnings data on Sunday, April, 11th. The company reported ($1.14) EPS for the quarter, missing the consensus estimate of ($0.04) by $1.10. The business earned $153.60 million during the quarter, compared to the consensus estimate of $172.01 million. Aphria had a negative trailing twelve-month return on equity of 2.30% and a negative net margin of 36.10%. Aphria's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.02 earnings per share.
Read the conference call transcript.

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV), Alibaba Group (BABA), Mastercard (MA), Block (SQ), Aurora Cannabis (ACB), Abbott Laboratories (ABT), Alteryx (AYX), Big Lots (BIG) and BlackRock (BLK).

This page (NASDAQ:APHA) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -